Soleno Therapeutics, Inc. logo

Soleno Therapeutics, Inc.

NASDAQ:SLNO

Overview | Financials
Company Name Soleno Therapeutics, Inc.
Symbol SLNO
Currency USD
Price 53.55
Market Cap 2,081,574,180
Dividend Yield 0%
52-week-range 3.96 - 54.5
Industry Biotechnology
Sector Healthcare
CEO Dr. Anish Bhatnagar M.D.
Website https://soleno.life

An error occurred while fetching data.

About Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development

Related Stocks

Cosmos Health Inc. logo

Cosmos Health Inc.

COSM

1.11 USD

Acutus Medical, Inc. logo

Acutus Medical, Inc.

AFIB

0.083 USD

Financials

Numbers are in millions USD

Numbers are in millions USD